Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Biomarkers for Alzheimer's dis...
  • Citiraj
  • Pošljite SMS
  • Pošljite email
  • Natisni
  • Izvozi zadetek
    • Izvozi v RefWorks
    • Izvozi v EndNoteWeb
    • Izvozi v EndNote
  • Permanent link
Biomarkers for Alzheimer's disease therapeutic trials

Biomarkers for Alzheimer's disease therapeutic trials

Show other versions (1)
Bibliografske podrobnosti
Main Authors: Hampel, H, Wilcock, G, Andrieu, S, Aisen, P, Blennow, K, Broich, K, Carrillo, M, Fox, N, Frisoni, G, Isaac, M, Lovestone, S, Nordberg, A, Prvulovic, D, Sampaio, C, Scheltens, P, Weiner, M, Winblad, B, Coley, N, Vellas, B
Format: Journal article
Izdano: 2010
  • Zaloga
  • Opis
  • Other Versions (1)
  • Podobne knjige/članki
  • Knjižničarski pogled
Showing 1 - 1 results of 1
Show all versions (2)
Search Result 1
Biomarkers for Alzheimer's disease therapeutic trials.

Biomarkers for Alzheimer's disease therapeutic trials. od Hampel, H, Wilcock, G, Andrieu, S, Aisen, P, Blennow, K, Broich, K, Carrillo, M, Fox, N, Frisoni, G, Isaac, M, Lovestone, S, Nordberg, A, Prvulovic, D, Sampaio, C, Scheltens, P, Weiner, M, Winblad, B, Coley, N, Vellas, B

Izdano 2011
Journal article
Show all versions (2)

Podobne knjige/članki

  • Biomarkers for Alzheimer's disease therapeutic trials.
    od: Hampel, H, et al.
    Izdano: (2011)
  • Endpoints for trials in Alzheimer's disease: a European task force consensus.
    od: Vellas, B, et al.
    Izdano: (2008)
  • Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
    od: Vellas, B, et al.
    Izdano: (2013)
  • Disease-modifying trials in Alzheimer's disease: a European task force consensus.
    od: Vellas, B, et al.
    Izdano: (2007)
  • Methodological issues in primary prevention trials for neurodegenerative dementia.
    od: Andrieu, S, et al.
    Izdano: (2009)

Iskalne možnosti

  • Iskalna zgodovina
  • Napredno iskanje

Poišči več

  • Prelistaj katalog
  • Po abecedi
  • Explore Channels
  • Obvezna literatura
  • Novi knjige/članki

Potrebujete pomoč?

  • Navodila za iskanje
  • Vprašaj knjižničarja
  • Pogosta vprašanja